NEWS / IR
-
2023. 02. 28IRCellusion Director and Executive Appointments
-
2022. 10. 12IRCellusion and Minaris Regenerative Medicine, a Member of Showa Denko Materials, Enter into Business Alliance for CLS001 Global Development
-
2022. 09. 12IRCellusion and Celregen, a member of Fosun Pharma, Enter into License Agreement of CLS001
-
2022. 06. 29IRThe CLS001 FIH study infomaiton was disclosed in jRCT.
-
2022. 03. 23IRPublic Announcement of Financial Results of the 7th Fiscal Year and Capital Reduction
-
2022. 03. 23IRCellusion and Toyo Seikan Group Holdings enter Capital and Business Alliance of CLS001 for Corneal Endothelial Cell Regenerative Therapy
-
2022. 03. 01IRCellusion established the Board of Corporate Auditors
-
2022. 03. 01IRAnnouncement of Changes to Officer Personnel
-
2022. 01. 07IRCellusion Raises 1.1B JPY to Advance Japan and Global Clinical Trials of CLS001 for Corneal Endothelial Cell Regenerative Therapy
-
2022. 01. 07IRCellusion and Toho Holdings enter Capital and Business Alliance of CLS001 for Corneal Endothelial Cell Regenerative Therapy
